Status:
COMPLETED
CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communication
Lead Sponsor:
Maastricht University Medical Center
Collaborating Sponsors:
Zuyderland Medical Centre
Leiden University Medical Center
Conditions:
COVID-19
Long COVID
Eligibility:
All Genders
18+ years
Brief Summary
The CORFU study, funded by ZonMW, is a prospective, multiple, cohort study with a maximum follow-up of 24 months after COVID-19. Dutch COVID-19 patients from 7 existing prospective cohorts, aiming and...
Eligibility Criteria
Inclusion
- All 7 existing cohorts have specific inclusion and exclusion criteria.
- For the CORFU study, in general, the criteria are:
- Patients with proven or suspected COVID-19:
- Confirmed (or suspected) COVID-19 - both home-isolated patients and patients who were admitted to the hospital ward and/or ICU;
- Included in one of the seven cohorts from March 2020 onwards;
- Aged 18 years or older;
- Mastering the Dutch language sufficiently to answer the questionnaires;
- Informed consent.
- Controls who did not experience COVID-19:
- Aged 18 years or older;
- Mastering the Dutch language sufficiently to answer the questionnaires;
- Informed consent.
- There were no exclusion criteria.
Exclusion
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
4291 Patients enrolled
Trial Details
Trial ID
NCT05240742
Start Date
October 1 2021
End Date
November 1 2024
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center+
Maastricht, Netherlands, 6229HX